PlumX Metrics
Embed PlumX Metrics

Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic

European Journal of Pediatrics, ISSN: 0340-6199, Vol: 172, Issue: 5, Page: 631-638
2013
  • 16
    Citations
  • 0
    Usage
  • 37
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country

Introduction Medication error (ME) is any preventable event that may lead to inappropriate use of medicines or patient harm while the patient or health professional

Article Description

Drug interactions are important potential causes of adverse drug reactions. However, studies of their occurrence in children are almost entirely lacking. This study evaluates the incidence of potential drug interactions (PDIs) in medication prescriptions for children. The study was performed at the University Hospital in Olomouc. PDIs in each patient's prescriptions were identified. Multivariate analysis was performed in order to assess the risk factors confounding the potential interactions. Univariate analysis was used to assess which diagnostic groups and medication groups significantly increase or lower the odds of a potential drug-drug interaction. A total of 6,078 patients meeting the inclusion criteria entered the study. They received 19,522 prescriptions. PDIs were identified in 3.83 % of patients (moderate-to-severe cases in 0.47 %). Patient age (p=0.008), the average number of prescriptions per visit (p0.0001), and the number of visits per year (p0.0001) were found to increase the risk of drug interaction. The presence of epilepsy, leukemia, or rheumatoid arthritis and related disease diagnoses were discovered to increase the risk of PDIs significantly. Conclusion: The risk of PDIs in children is low, but it increases significantly with age and the number of drugs prescribed, particularly antiepi-leptics and immunosuppressants. The finding of a potential interaction in 0.47 % of all children in whom any medication was prescribed should not be underestimated since it means a significant risk for one child out of every 200, and it is also substantially higher in the chronically ill. Pediatricians should be aware of relevant interactions and should prevent them by therapeutic drug monitoring or appropriate clinical and laboratory monitoring. © 2013 Springer-Verlag Berlin Heidelberg.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know